This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Infectious Diseases, Other  • World Health  • Public Health, Other  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A Systematic Review

Caryn Bern, MD, MPH; Susan P. Montgomery, DVM, MPH; Barbara L. Herwaldt, MD, MPH; Anis Rassi Jr, MD, PhD; Jose Antonio Marin-Neto, MD, PhD; Roberto O. Dantas, MD; James H. Maguire, MD, MPH; Harry Acquatella, MD; Carlos Morillo, MD; Louis V. Kirchhoff, MD, MPH; Robert H. Gilman, MD, DTM&H; Pedro A. Reyes, MD; Roberto Salvatella, MD; Anne C. Moore, MD, PhD

JAMA. 2007;298(18):2171-2181.

Context  Because of population migration from endemic areas and newly instituted blood bank screening, US clinicians are likely to see an increasing number of patients with suspected or confirmed chronic Trypanosoma cruzi infection (Chagas disease).

Objective  To examine the evidence base and provide practical recommendations for evaluation, counseling, and etiologic treatment of patients with chronic T cruzi infection.

Evidence Acquisition  Literature review conducted based on a systematic MEDLINE search for all available years through 2007; review of additional articles, reports, and book chapters; and input from experts in the field.

Evidence Synthesis  The patient newly diagnosed with Chagas disease should undergo a medical history, physical examination, and resting 12-lead electrocardiogram (ECG) with a 30-second lead II rhythm strip. If this evaluation is normal, no further testing is indicated; history, physical examination, and ECG should be repeated annually. If findings suggest Chagas heart disease, a comprehensive cardiac evaluation, including 24-hour ambulatory ECG monitoring, echocardiography, and exercise testing, is recommended. If gastrointestinal tract symptoms are present, barium contrast studies should be performed. Antitrypanosomal treatment is recommended for all cases of acute and congenital Chagas disease, reactivated infection, and chronic T cruzi infection in individuals 18 years or younger. In adults aged 19 to 50 years without advanced heart disease, etiologic treatment may slow development and progression of cardiomyopathy and should generally be offered; treatment is considered optional for those older than 50 years. Individualized treatment decisions for adults should balance the potential benefit, prolonged course, and frequent adverse effects of the drugs. Strong consideration should be given to treatment of previously untreated patients with human immunodeficiency virus infection or those expecting to undergo organ transplantation.

Conclusions  Chagas disease presents an increasing challenge for clinicians in the United States. Despite gaps in the evidence base, current knowledge is sufficient to make practical recommendations to guide appropriate evaluation, management, and etiologic treatment of Chagas disease.

Author Affiliations: Parasitic Diseases Branch, Division of Parasitic Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Bern, Montgomery, Herwaldt, and Moore); Anis Rassi Hospital, Goiania, Brazil (Dr Rassi); Medical School of Ribeirão Preto, University of Sao Paulo, Ribeirão Preto, Sao Paolo, Brazil (Drs Marin-Neto and Dantas); University of Maryland, Baltimore (Dr Maguire); Universidad Central de Venezuela, Caracas, Venezuela (Dr Acquatella); McMaster University, Hamilton, Ontario, Canada (Dr Morillo); University of Iowa, Iowa City (Dr Kirchhoff); Johns Hopkins University, Baltimore, Maryland (Dr Gilman); I. Chávez National Institute of Cardiology, Mexico City, Mexico (Dr Reyes); and Pan American Health Organization, Montevideo, Uruguay (Dr Salvatella).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Organ Transplantation and Chagas Disease
Javier D. Altclas, Laura Barcan, Claudia Nagel, Roberta Lattes, and Adelina Riarte
JAMA. 2008;299(10):1134.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Chagas Disease
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2007;298(18):2222.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis
Perez-Molina et al.
J Antimicrob Chemother 2009;64:1139-1147.
ABSTRACT | FULL TEXT  

Imaging Spectrum of Bites, Stings, and Their Complications: Self-Assessment Module
Roberts et al.
Am. J. Roentgenol. 2009;193:S42-S45.
ABSTRACT | FULL TEXT  

Lateral Flow Immunoassay for Diagnosis of Trypanosoma cruzi Infection with High Correlation to the Radioimmunoprecipitation Assay
Houghton et al.
CVI 2009;16:515-520.
ABSTRACT | FULL TEXT  

Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease
Rassi et al.
Heart 2009;95:524-534.
ABSTRACT | FULL TEXT  

Polymerase Chain Reaction for Chronic Trypanosoma cruzi Infection Yields Higher Sensitivity in Blood Clot Than Buffy Coat or Whole Blood Specimens
Fitzwater et al.
Am J Trop Med Hyg 2008;79:768-770.
ABSTRACT | FULL TEXT  

Organ Transplantation and Chagas Disease
Altclas et al.
JAMA 2008;299:1134-1134.
FULL TEXT